Dermatology · North Miami Beach, FL
NPI
1003823253
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
17101 NE 19th Ave, Suite 101
North Miami Beach, FL, 33162
Phone (305) 940-7766
Groups this clinician bills Medicare through
Medicare paid, 2024
$169K
2,015 services
Medicare patients, 2024
361
Average age 73
Drug cost, 2024
$1.2M
5,176 prescriptions
Company payments, 2025
$5,749
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul F Rockley was code 99214 (office e&m - established), 522 times for 271 patients. In total Paul F Rockley billed 2,015 services in 63 codes, and Medicare paid $169K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-24.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 522 | 271 | $97.69 | $51K |
| 88305 Surgical Pathology Examination | Office | 284 | 156 | $57.04 | $16K |
| 17003 Destruction Skin Lesion | Office | 284 | 107 | $5.19 | $1,473 |
| 17000 Destruction Skin Lesion | Office | 241 | 148 | $41.70 | $10K |
| 11102 Skin Biopsy | Office | 171 | 130 | $70.98 | $12K |
| 99204 Office E&M - New | Office | 87 | 87 | $128.53 | $11K |
| 17110 Destruction Skin Lesion | Office | 40 | 29 | $89.45 | $3,578 |
| 11103 Skin Biopsy | Office | 37 | 32 | $40.34 | $1,493 |
| 11900 Skin | Office | 27 | 18 | $38.31 | $1,034 |
| 17313 Mohs Surgery | Office | 25 | 23 | $461.56 | $12K |
| 17311 Mohs Surgery | Office | 23 | 19 | $431.83 | $9,932 |
| 17281 Destruction Skin Lesion | Office | 22 | 17 | $139.28 | $3,064 |
| 17261 Destruction Skin Lesion | Office | 20 | 14 | $80.44 | $1,609 |
| 11104 Skin Biopsy | Office | 20 | 19 | $94.32 | $1,886 |
| 17262 Destruction Skin Lesion | Office | 20 | 15 | $124.77 | $2,495 |
By year: 2022 $219K for 2,980 services; 2023 $213K for 2,700 services; 2024 $169K for 2,015 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88305 Surgical Pathology Examination | 284 | 156 | $57.04 | $16K |
| 88312 Surgical Pathology Examination | 16 | 14 | $90.51 | $1,448 |
Medicare prescription drug claims, 2024
In 2024, the drug Paul F Rockley prescribed most often to Medicare patients was Triamcinolone Acetonide, with 711 prescriptions and refills. In total Paul F Rockley wrote 5,176 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 711 | 760 | 443 | $13K |
| Clobetasol Propionate Generic | 653 | 671 | 362 | $19K |
| Ketoconazole Generic | 334 | 413 | 126 | $6,182 |
| Ammonium Lactate Generic | 334 | 354 | 186 | $9,305 |
| Mupirocin Generic | 333 | 338 | 236 | $2,552 |
| Fluocinolone Acetonide Fluocinolone/Shower Cap | 259 | 261 | 126 | $15K |
| Clotrimazole Generic | 234 | 241 | 129 | $4,092 |
| Clindamycin Phosphate Generic | 231 | 242 | 100 | $5,804 |
| Hydrocortisone Generic | 213 | 231 | 125 | $1,174 |
| Mometasone Furoate Generic | 191 | 200 | 104 | $3,234 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 178 | 184 | 112 | $9,186 |
| Permethrin Generic | 117 | 117 | 77 | $3,601 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 101 | 105 | 75 | $2,142 |
| Doxycycline Hyclate Generic | 100 | 102 | 67 | $2,755 |
| Tacrolimus Generic | 95 | 96 | 55 | $14K |
Brand drugs: 278 claims; generic drugs: 4,898 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul F Rockley $5,749 ($5,749 in general payments such as food, travel and fees) from 15 companies. The largest payer was Galderma Laboratories, L.P. with $3,093.
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. GALD.SW | 12 | $3,093 |
| Abbvie Inc. ABBV | 21 | $433 |
| Janssen Biotech, Inc. JNJ | 13 | $417 |
| UCB, Inc. UCB.BR | 6 | $382 |
| Genzyme Corporation SNY | 10 | $347 |
| Pfizer Inc. PFE | 8 | $318 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $209 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $197 |
| LEO Pharma Inc. | 4 | $108 |
| Cipher Pharmaceuticals US LLC CPH.TO | 1 | $87.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.